Randomized clinical trials and observational studies: guidelines for assessing respective strengths and limitations.

[1]  J. H. Mitchell.  Medical aid to vietnam. , 1969, The Medical journal of Australia.

[2]  D. Rubin,et al.  The central role of the propensity score in observational studies for causal effects , 1983 .

[3]  D. Rubin,et al.  Reducing Bias in Observational Studies Using Subclassification on the Propensity Score , 1984 .

[4]  A. Detsky,et al.  Evidence-based medicine. A new approach to teaching the practice of medicine. , 1992, JAMA.

[5]  E L Hannan,et al.  Clinical Versus Administrative Data Bases for CABG Surgery: Does it Matter , 1992, Medical care.

[6]  G. Coffman,et al.  Predicting In-Hospital Mortality: A Comparison of Severity Measurement Approaches , 1992, Medical care.

[7]  E. DeLong,et al.  Discordance of Databases Designed for Claims Payment versus Clinical Information Systems: Implications for Outcomes Research , 1993, Annals of Internal Medicine.

[8]  C. Viscoli,et al.  The relationship of treatment adherence to the risk of death after myocardial infarction in women. , 1993, JAMA.

[9]  B J McNeil,et al.  Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables. , 1994, JAMA.

[10]  L I Iezzoni,et al.  Predicting Who Dies Depends on How Severity Is Measured: Implications for Evaluating Patient Outcomes , 1995, Annals of Internal Medicine.

[11]  N. Black.  Why we need observational studies to evaluate the effectiveness of health care , 1996, BMJ.

[12]  U. P. S. T. Force.  Guide to Clinical Preventive Services: Report of the U S Preventive Services Task Force , 1996 .

[13]  E. Hannan,et al.  Using Medicare claims data to assess provider quality for CABG surgery: does it work well enough? , 1997, Health services research.

[14]  E. Barrett-Connor,et al.  Hormone replacement therapy, heart disease, and other considerations. , 1998, Annual review of public health.

[15]  C Bain,et al.  Interpreting the evidence: choosing between randomised and non-randomised studies , 1999, BMJ.

[16]  J. Buring,et al.  Women in clinical trials--a portfolio for success. , 2000, The New England journal of medicine.

[17]  J. Concato,et al.  Randomized, controlled trials, observational studies, and the hierarchy of research designs. , 2000, The New England journal of medicine.

[18]  A. Hartz,et al.  A comparison of observational studies and randomized, controlled trials , 2000, American journal of ophthalmology.

[19]  J. Ioannidis,et al.  Comparison of evidence of treatment effects in randomized and nonrandomized studies. , 2001, JAMA.

[20]  R. Stables.  Observational research in the evidence based environment: eclipsed by the randomised controlled trial? , 2002, Heart.

[21]  Harlan M Krumholz,et al.  Representation of the elderly, women, and minorities in heart failure clinical trials. , 2002, Archives of internal medicine.

[22]  Nick Freemantle,et al.  Composite outcomes in randomized trials: greater precision but with greater uncertainty? , 2003, JAMA.

[23]  E. Topol,et al.  Clinical trials--multiple treatments, multiple end points, and multiple lessons. , 2003, JAMA.

[24]  Harlan M Krumholz,et al.  Participation in cancer clinical trials: race-, sex-, and age-based disparities. , 2004, JAMA.

[25]  Facts About Menopausal Hormone Therapy , 2005 .

[26]  E. Hannan,et al.  Outcomes of planned home births with certified professional midwives: large prospective study in North America , 2005, BMJ : British Medical Journal.

[27]  J. Tijssen,et al.  Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. , 2006, The New England journal of medicine.

[28]  K. Rothman,et al.  Beyond randomized controlled trials: A critical comparison of trials with nonrandomized studies , 2006, Hepatology.

[29]  Samin K. Sharma,et al.  Impact of Completeness of Percutaneous Coronary Intervention Revascularization on Long-Term Outcomes in the Stent Era , 2006, Circulation.

[30]  G. Guyatt,et al.  Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. , 2006, Chest.

[31]  D. Berman,et al.  Optimal medical therapy with or without PCI for stable coronary disease. , 2007, The New England journal of medicine.

[32]  Ralph B D'Agostino,et al.  Estimating treatment effects using observational data. , 2007, JAMA.

[33]  D. Grobbee,et al.  Cognitive and cardiac outcomes 5 years after off-pump vs on-pump coronary artery bypass graft surgery. , 2007, JAMA.

[34]  D. Hoaglin,et al.  Enhancement of claims data to improve risk adjustment of hospital mortality. , 2007, JAMA.

[35]  Off-Pump Versus On-Pump Coronary Artery Bypass Graft Surgery: Differences in Short-Term Outcomes and in Long-Term Mortality and Need for Subsequent Revascularization , 2007 .

[36]  P. Teirstein,et al.  The truth and consequences of the COURAGE trial. , 2007, Journal of the American College of Cardiology.